Carevitra

What Is Carevitra?

Carevitra is a prescription-strength oral medication manufactured by Careclub Pharmaceuticals LLP, an established Indian pharmaceutical company with an international export footprint covering the United States, United Kingdom, Germany, the Netherlands, and Italy. Carevitra contains vardenafil hydrochloride as its active ingredient — the identical compound found in brand-name Levitra, the FDA-approved vardenafil product originally developed by Bayer AG. As a bioequivalent generic of Levitra, Carevitra delivers the same clinically proven therapeutic outcomes at a dramatically more accessible price point, making it one of the most competitively priced and effective vardenafil options available to American men today.

Vardenafil belongs to the PDE5 (phosphodiesterase type 5) inhibitor class — the most medically significant drug class in the treatment of erectile dysfunction. Unlike its more widely known class-mates sildenafil (Viagra) and tadalafil (Cialis), vardenafil has a pharmacological profile that distinguishes it in clinically important ways: it demonstrates superior PDE5 binding selectivity, significantly lower inhibition of PDE6 (the enzyme responsible for visual processing in the retina), and a robust clinical efficacy in diabetic patients that has been demonstrated across multiple dedicated clinical trials. For millions of American men — particularly those who have experienced visual side effects with sildenafil or who have diabetes — Carevitra represents a meaningfully different and often better-tolerated option.

At ED Care Store, we carry Carevitra across all three available strengths — 20 mg, 40 mg, and 60 mg — so every man can find the dose that best fits his clinical needs and the guidance of his physician. Browse our complete Carevitra collection to see all available options with transparent pricing and discreet, reliable delivery.

This guide covers everything: the pharmacology of vardenafil, each Carevitra strength explained in detail, a complete dosage guide, onset and duration, side effects, contraindications, drug interactions, how Carevitra compares to other ED medications, and how to make the most of your treatment.

Erectile Dysfunction in America: Why This Matters More Than Ever

Erectile dysfunction is one of the most prevalent and most undertreated conditions in American men's health. Understanding the true scope of the problem is the first step toward overcoming the stigma that prevents so many men from seeking effective treatment:

• 30 million American men are estimated to be affected by some degree of erectile dysfunction, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
• 52% of men aged 40 to 70 reported experiencing ED in the landmark Massachusetts Male Aging Study — the most comprehensive longitudinal study of male sexual health ever conducted in the United States.
• 1 in 4 new ED patients is under 40 years old, a growing trend driven by psychological factors, lifestyle habits (sedentary behavior, poor diet, smoking), and early-onset cardiovascular risk factors including hypertension and metabolic syndrome.
• Fewer than 25% of affected men seek treatment — primarily because of embarrassment, social stigma, or the misbelief that nothing effective is available. This is the access and awareness gap that drives everything we do.

ED is not a normal or inevitable consequence of aging. It is a medical condition with highly effective, evidence-based treatments. Carevitra — and vardenafil more broadly — is one of those treatments, backed by decades of rigorous clinical research and real-world clinical use across millions of men worldwide.

How Does Carevitra Work? The Vardenafil Pharmacology Explained

The Normal Erection Process

An erection is a complex, multi-system event that begins with sexual stimulation — physical, psychological, or both. Stimulation triggers the peripheral nervous system to release nitric oxide (NO) into the smooth muscle of the corpus cavernosum, the spongy erectile tissue running through the length of the penis. Nitric oxide activates an enzyme called guanylate cyclase, which produces cyclic guanosine monophosphate (cGMP) — the key intracellular messenger that causes smooth muscle in the penile arteries to relax. When this smooth muscle relaxes, resistance to blood flow decreases dramatically, blood rushes into the erectile chambers, and the penis becomes engorged and firm.

The entire process is dependent on cGMP remaining at adequate levels throughout sexual activity. The enzyme PDE5 (phosphodiesterase type 5) is naturally responsible for breaking down cGMP — this is how an erection subsides after ejaculation or when stimulation stops. In men with erectile dysfunction, however, PDE5 activity is dysregulated, degrading cGMP too rapidly during sexual stimulation and preventing sufficient blood engorgement to produce or sustain an adequate erection.

How Vardenafil Intervenes

Vardenafil is a potent, competitive inhibitor of PDE5. By occupying the PDE5 enzyme's active site, it prevents cGMP from being broken down during sexual stimulation, allowing cGMP concentrations to remain elevated, smooth muscle to stay relaxed, and blood flow into the penis to be sustained — producing and maintaining the erection necessary for satisfactory sexual intercourse.

An absolutely critical point: vardenafil — like all PDE5 inhibitors — does not produce erections in the absence of sexual stimulation. It does not create desire. It does not generate arousal. It amplifies and sustains the physiological erection response that sexual arousal triggers. Sexual stimulation is not optional — it is a pharmacological requirement for vardenafil to work.

Why Vardenafil's PDE5 Selectivity Is a Genuine Clinical Advantage

Not all PDE5 inhibitors are equally selective. The human body contains over 11 distinct phosphodiesterase enzyme subtypes (PDE1 through PDE11), distributed across different tissues and serving different physiological functions. A drug's selectivity profile — how strongly it inhibits PDE5 relative to other PDE subtypes — has direct clinical implications.

Vardenafil demonstrates among the highest PDE5 affinity and selectivity of any approved PDE5 inhibitor. Critically, it shows significantly lower inhibition of PDE6 compared to sildenafil. PDE6 is expressed almost exclusively in the photoreceptors of the retina and is responsible for the phototransduction cascade — how the eye converts light into nerve signals. Sildenafil's moderate PDE6 inhibition is the pharmacological basis for the visual disturbances — blue-tinge vision, increased light sensitivity, blurred vision — that some men experience with Viagra. Because vardenafil is far more selective for PDE5 over PDE6, these visual side effects are significantly rarer and milder with vardenafil than with sildenafil.

Vardenafil also shows minimal inhibition of PDE1 and PDE3 — enzymes relevant to cardiac contractility — contributing to its clean cardiovascular safety profile. Its effect on PDE11 (found in skeletal muscle) is also substantially lower than tadalafil's, which is why the back pain and muscle aches characteristic of tadalafil are notably less common with vardenafil.

Carevitra Strengths: Every Variant Explained

Carevitra is available in three strengths, each designed for a specific clinical scenario. Choosing the right strength should always be done in consultation with a licensed healthcare provider, who will consider your overall health profile, any co-existing conditions, and any medications you take.

Carevitra 20 mg — The Clinical Standard

Carevitra 20 mg is the benchmark formulation and the most closely parallel to the original Levitra 20 mg prescription. The 20 mg dose is the standard FDA-approved as-needed dose for most adult men and is the most frequently prescribed vardenafil strength in clinical practice globally. A single tablet taken 30 to 60 minutes before sexual activity produces reliable PDE5 inhibition, enabling erections that are firmer, more consistent, and more sustained than without medication.

This is the correct starting dose for the large majority of men new to Carevitra. It strikes the optimal balance between therapeutic efficacy and side-effect profile for most patients, and it corresponds precisely to the pivotal clinical trial dose on which vardenafil's FDA approval was based.

Carevitra 40 mg — Enhanced Strength

Carevitra 40 mg is intended for men who have tried Carevitra 20 mg and found that while it produced some benefit, the response was partial or inconsistent. At double the standard starting dose, 40 mg delivers significantly stronger PDE5 inhibition and a more reliable erectile response across a broader range of clinical situations — including men with moderate ED secondary to diabetes, post-surgical nerve damage, or significant vascular disease.

Dose titration from 20 mg to 40 mg should always be performed under physician supervision. It is not a recommended first-line dose for men new to vardenafil. The potential for side effects — headache, flushing, blood pressure effects — increases proportionally with dose, and physician oversight ensures the benefit-risk balance is appropriate for your individual health profile.

Carevitra 60 mg — Maximum Strength

Carevitra 60 mg is the highest-strength vardenafil formulation we carry. It is designed for men with more pronounced or treatment-resistant erectile dysfunction, where lower doses have demonstrated insufficient clinical response. This strength significantly exceeds the typical U.S. clinical dosing guidance (which sets the maximum approved dose at 20 mg for most patient populations) and should therefore be used exclusively under close medical supervision.

It is a powerful formulation with a correspondingly stronger side-effect potential. Men considering Carevitra 60 mg should have an established relationship with their prescribing physician, a clear clinical rationale for the higher dose, and a thorough discussion of risks, monitoring, and stopping criteria.

Carevitra Dosage Guide: How Much, When, and How Often

Use this table as your quick-reference dosing guide. Always follow your physician's specific prescription instructions — this table is informational, not a substitute for individual medical advice.

* 10 mg (half-tablet of Carevitra 20 mg) may be an appropriate conservative starting dose for older men or those on interacting medications — discuss with your physician.

Core Dosing Rules for All Carevitra Variants

• Take 30 to 60 minutes before sexual activity. Most men experience the onset of effect within this window. On a light stomach, effects may begin closer to 25 to 30 minutes. A heavy high-fat meal may delay onset to 60 minutes or beyond.
• Maximum one dose per 24 hours — no exceptions. Do not take a second dose within 24 hours if the first dose didn't produce the expected result. Discuss the issue with your physician before your next use.
• Sexual stimulation is absolutely necessary. Carevitra will not produce an erection in the absence of sexual arousal. The drug amplifies the erection response to stimulation; it cannot generate it independently.
• Swallow the tablet whole with water. Do not crush, chew, or break standard film-coated Carevitra tablets. This disrupts the controlled release of the active ingredient and may produce an uneven plasma concentration profile.
• Avoid grapefruit and grapefruit juice. Grapefruit contains furanocoumarins that inhibit CYP3A4, the primary liver enzyme responsible for vardenafil metabolism. This can cause unpredictable increases in vardenafil plasma concentration. Avoid grapefruit products entirely throughout treatment.
• Moderate alcohol only. One to two standard alcoholic drinks alongside Carevitra is generally tolerable. Excessive alcohol independently impairs erectile function, reduces testosterone levels, and adds to vardenafil's blood-pressure-lowering effect — counteracting the medication's benefits and increasing risk.
• No re-dosing. If the dose did not work as expected, do not take a second tablet. Re-evaluate timing, stimulation, food and alcohol intake. Discuss with your physician before the next use.

Onset and Duration: What to Expect from Carevitra

How Quickly Does Carevitra Work?

Most men experience the onset of Carevitra's effects within 25 to 60 minutes of taking the tablet. Clinical pharmacokinetic data show that vardenafil reaches peak plasma concentrations (Tmax) at approximately 30 to 120 minutes after oral dosing in most adults, with a median Tmax of approximately 60 minutes for the standard film-coated tablet. However, individual onset times vary considerably based on several modifiable factors (see below).

In controlled clinical studies, some men reported noticing the onset of improved erectile responsiveness in as little as 15 to 25 minutes — faster than is commonly reported with sildenafil in typical real-world conditions. This faster onset is attributed to vardenafil's pharmacokinetic properties and is one reason some men and their physicians prefer vardenafil over sildenafil when onset speed is a priority.

How Long Does Carevitra Last?

The therapeutic window for Carevitra — the period during which enhanced erectile responsiveness can be reliably expected — is approximately 4 to 6 hours for most men. Some men report effects somewhat beyond this window, though with progressively diminishing intensity as plasma vardenafil concentrations decline. The plasma half-life of vardenafil is approximately 4 to 5 hours.

This duration positions Carevitra similarly to sildenafil (4 to 5 hours) but importantly distinguishes it from tadalafil (Cialis / Vidalista), which lasts up to 36 hours. For men who prefer a finite, well-defined therapeutic window rather than multi-day coverage, this is often a practical preference. The therapeutic "on/off" character of vardenafil and sildenafil appeals to men who want the medication to be active when they choose and not present in their system the next morning.

Factors That Affect Onset and Duration

• Food: A light meal has minimal impact. A high-fat meal (a burger, fried foods, heavy cream-based dishes) significantly delays gastric emptying and vardenafil absorption, pushing onset time back considerably. For best results, take Carevitra at least 2 hours after a heavy meal, or on a relatively empty stomach.
• Alcohol: Beyond a moderate amount, alcohol slows gastric emptying, suppresses nitric oxide production, and directly impairs the erectile response. Heavy drinking before using Carevitra significantly reduces its effectiveness.
• Grapefruit: Grapefruit inhibits CYP3A4 and can raise vardenafil blood levels unpredictably, potentially intensifying both efficacy and side effects. Avoid entirely.
• Age: Older men have slower hepatic metabolism, leading to higher peak vardenafil plasma concentrations and a longer effective half-life. This is why a starting dose of 5 to 10 mg is recommended for men over 65.
• Psychological state: Anxiety, stress, and distraction directly impair the nervous system's ability to initiate and sustain the arousal response. Performance anxiety is one of the most common reasons a first dose of any PDE5 inhibitor appears ineffective. The medication requires genuine arousal to demonstrate its effect.

Carevitra vs. Other ED Medications: The Definitive Comparison

Understanding how Carevitra compares to sildenafil and tadalafil is essential for making an informed treatment choice. Here is a full side-by-side comparison:

When to Choose Carevitra Over Sildenafil

Carevitra is particularly worth considering over sildenafil-based options if: (1) you have experienced visual disturbances (blue-tinge, light sensitivity) with sildenafil; (2) you have diabetes, as vardenafil's clinical efficacy data in diabetic populations is especially strong; (3) you prefer a slightly faster onset; or (4) a high-fat meal is likely to precede sexual activity and you need a drug less sensitive to food interaction. For men who want to explore our sildenafil range, we carry a comprehensive Blue Pill sildenafil collection including Cenforce, Fildena, Kamagra, Malegra, and more.

When to Choose Carevitra Over Tadalafil

Choose Carevitra if you prefer a finite therapeutic window rather than 36-hour coverage, if back pain and muscle aches (characteristic of tadalafil) have been a problem, or if you specifically value the fast-onset option in vardenafil's profile. For men who want the 36-hour spontaneity window and BPH dual coverage, our Tadalafil collection — including Vidalista, Tadalista, Tadarise, and others — is worth exploring.

Carevitra vs. Other Vardenafil Generics in Our Store

We carry three vardenafil generic brands. Here is how Carevitra compares to its stablemates in our Vardenafil collection:

Carevitra vs. Vilitra

Both Carevitra and Vilitra contain identical vardenafil active ingredient. The pharmacological effect is the same — bioequivalent. Vilitra is manufactured by Centurion Laboratories (the same company that produces Vidalista and Cenforce), has an extensive global track record, and comes in a broad range of standard strengths. Carevitra is manufactured by Careclub Pharmaceuticals and is favored by men who prefer its specific tablet coating and formulation characteristics. Some men develop a mild preference for one over the other based on individual digestive response or tablet coating — never the pharmacological action of vardenafil itself.

Carevitra vs. Snovitra

Snovitra is another high-quality vardenafil generic in our portfolio. Like Carevitra, it contains the same active ingredient and delivers bioequivalent vardenafil exposure. Snovitra is popular for its competitive per-tablet pricing and is a reliable alternative for men who want straightforward vardenafil at a very accessible cost. The choice between Snovitra and Carevitra often comes down to personal preference, availability at a specific dose, and individual response to excipient profiles.

Clinical Evidence: What Research Shows About Vardenafil

Pivotal FDA Approval Trials

Vardenafil's FDA approval (August 2003) was supported by a comprehensive clinical development program involving thousands of men across multiple Phase III randomized controlled trials. The pivotal efficacy findings were:

• Men receiving vardenafil 10 mg and 20 mg demonstrated significantly greater improvements in the International Index of Erectile Function (IIEF) erectile function domain score — the gold-standard validated measure of erectile function — compared to placebo.
• Sexual Encounter Profile (SEP) question 2 (Was penetration successful?) and SEP question 3 (Was the erection sufficient to complete intercourse?) showed statistically significant and clinically meaningful improvements for vardenafil versus placebo in all major trial cohorts.
• Global Assessment Question (GAQ) positive response rates — men answering "Yes, treatment improved my erections" — reached 71 to 80% for vardenafil 10 to 20 mg versus approximately 35% for placebo across pivotal trials.

Vardenafil in Diabetic Men: Exceptionally Strong Evidence

Erectile dysfunction affects an estimated 50 to 75% of American men with diabetes. Both Type 1 and Type 2 diabetes damage erectile function through two primary mechanisms: diabetic neuropathy (nerve damage that impairs the neural signals initiating erection) and diabetic vasculopathy (endothelial dysfunction and microvascular disease that reduce blood flow to the penis).

Vardenafil has been studied in dedicated clinical trials specifically in diabetic populations, and the results are among the most compelling in the PDE5 inhibitor evidence base. In these trials, vardenafil produced statistically significant improvements in IIEF erectile function domain scores, successful penetration rates, and successful intercourse completion rates — with an efficacy profile comparable to that seen in non-diabetic men. This is clinically important because diabetic ED can be more refractory to treatment than ED from other causes.

The pharmacological basis for vardenafil's particular strength in diabetic men is believed to be its higher binding affinity for PDE5 and superior selectivity compared to sildenafil — enabling robust PDE5 inhibition even in the context of the partially impaired cGMP signaling that characterizes diabetic vascular dysfunction.

Head-to-Head Trials: Vardenafil vs. Sildenafil

Several head-to-head clinical studies have compared vardenafil and sildenafil directly. While both drugs demonstrated comparable overall efficacy in broad ED populations, vardenafil consistently showed advantages in specific areas: faster onset of action in a subset of patients, significantly fewer visual side effects (attributed to PDE6 selectivity differences), and superior efficacy in diabetic subgroups in several study analyses.

Long-Term Safety Data

Open-label extension studies of vardenafil have followed patients for up to two to four years of continuous treatment. These long-term data consistently demonstrate: (1) no development of pharmacological tolerance to the erectile effects of vardenafil over time; (2) a stable and predictable adverse event profile that does not worsen with continued exposure; (3) no cardiovascular safety signal of concern in men with appropriately managed cardiovascular risk factors.

Carevitra Side Effects: Complete and Honest Overview

Common Side Effects

• Headache: The most frequently reported adverse effect, occurring in approximately 15 to 21% of men in clinical trials. Caused by vasodilation beyond the penile vasculature — the widening of blood vessels that produces the therapeutic effect also affects cerebral and meningeal vessels. Typically mild to moderate, usually responsive to standard over-the-counter analgesics, and self-resolving within 2 to 4 hours.
• Facial flushing: Warmth and visible redness in the face, neck, and upper chest resulting from systemic vasodilation. Typically transient, lasting 1 to 3 hours from peak plasma concentration. Not medically dangerous but can be cosmetically noticeable.
• Nasal congestion: Mild stuffiness or rhinorrhea from vasodilation of the nasal mucosa. Generally mild, self-resolving within a few hours, and not a reason to discontinue the medication for most men.
• Indigestion (dyspepsia): Mild gastric discomfort, epigastric pain, or heartburn in a subset of men. Can often be reduced by taking the tablet with a small amount of food or immediately after eating — the food interaction primarily affects onset speed for heavy meals, not absorption completeness.
• Dizziness: Mild lightheadedness, particularly noticeable when standing quickly from a sitting or lying position, from the transient blood pressure reduction associated with PDE5 inhibition. Avoid abrupt postural changes in the hours following a dose. Lies down briefly if dizziness occurs.
• Nausea: Occasional gastric discomfort reported in a minority of users. Typically mild and resolves without intervention.

Less Common Side Effects

• Vision changes: Due to vardenafil's substantially lower PDE6 inhibition compared to sildenafil, visual disturbances — blurring, color-tinge vision, increased light sensitivity — are significantly less common with Carevitra than with sildenafil products. When they do occur, they are typically mild and transient.
• Sinusitis: Mild sinus inflammation or pressure, mechanistically related to nasal vasodilation.
• Back pain: Back pain or muscle aches (myalgia) occur less commonly with vardenafil than with tadalafil (where PDE11 inhibition in skeletal muscle is believed to be the mechanism). Occasional mild instances are reported with vardenafil.
• Photosensitivity: A mild increase in sensitivity to light, particularly sunlight, in a small minority of users. Sunglasses outdoors on the day of dosing may help.

Serious Side Effects — Seek Immediate Emergency Care

• Priapism: A sustained, painful erection lasting more than 4 hours that is not associated with sexual stimulation and does not subside. This is a medical emergency requiring immediate emergency room evaluation. Untreated priapism causes permanent ischemic damage to erectile tissue, with irreversible erectile dysfunction as the consequence. If a prolonged painful erection occurs, go to the emergency room immediately — do not wait and hope it resolves.
• Sudden vision loss (NAION): Non-arteritic anterior ischemic optic neuropathy — abrupt loss of vision in one or both eyes — has been reported in rare cases with PDE5 inhibitors, including vardenafil. While the causal relationship to vardenafil is not definitively established (pre-existing vascular risk factors appear to play a key role), the FDA requires a warning for all PDE5 inhibitors. Stop Carevitra immediately and seek emergency ophthalmologic care if any sudden vision change occurs.
• Sudden hearing loss: Sudden decrease or complete loss of hearing, sometimes accompanied by tinnitus (ringing in the ears) or vertigo, has been reported with PDE5 inhibitors. Discontinue Carevitra immediately and seek urgent medical evaluation if this occurs.
• Severe hypotension with nitrates: Combining vardenafil with any nitrate medication or recreational nitrate product produces a potentially fatal drop in blood pressure. This combination is absolutely and unconditionally contraindicated. See the full contraindications section below.
• Severe allergic reactions: Rare cases of serious hypersensitivity reactions — including rash, urticaria, angioedema (facial, lip, or throat swelling), and anaphylaxis — have been reported. Seek emergency care immediately if signs of severe allergic reaction occur after taking Carevitra.

Contraindications: Who Must Not Take Carevitra

Carevitra is medically contraindicated in the following situations. If any of these apply, do not take Carevitra without explicit physician clearance — some of these interactions are life-threatening:

• Nitrate medications — absolute contraindication, no exceptions: All forms of nitrate — nitroglycerin tablets, spray, or patches; isosorbide mononitrate (Imdur, ISMO); isosorbide dinitrate (Isordil); and recreational "popper" inhalants (amyl nitrate, amyl nitrite, butyl nitrite) — cause a severe and potentially fatal hypotensive response when combined with vardenafil. The interaction is pharmacologically unavoidable and cannot be managed by dose adjustment or timing. Men currently prescribed nitrates for angina, heart failure, or other conditions should not use Carevitra. Inform any emergency care provider that you have taken vardenafil if emergency nitrate administration becomes necessary.
• Riociguat (Adempas) — absolute contraindication: Riociguat is a soluble guanylate cyclase stimulator used for pulmonary arterial hypertension. Its combination with PDE5 inhibitors produces excessive and potentially dangerous blood pressure lowering. Absolutely contraindicated.
• Severe hepatic impairment (Child-Pugh Class C): Vardenafil is primarily metabolized by the liver via CYP3A4. In severe hepatic disease, this metabolism is critically impaired, leading to dangerous accumulation of vardenafil. Carevitra is contraindicated in this population.
• Congenital or acquired QT prolongation: Vardenafil — uniquely among the three major PDE5 inhibitors — has demonstrated dose-dependent QT interval prolongation on the electrocardiogram at supratherapeutic doses. This effect is clinically relevant for men with pre-existing QT prolongation (congenital long QT syndrome, hypokalemia, hypomagnesemia, or concurrent QT-prolonging drug therapy). Men with confirmed QT prolongation or who are taking drugs known to prolong QT (amiodarone, sotalol, quinidine, disopyramide, procainamide) should not use vardenafil without cardiological evaluation.
• Recent major cardiovascular events: Men who have had a myocardial infarction within the past 90 days, a stroke within the past 6 months, or who have severe or decompensated heart failure should not use Carevitra until cardiac stability is re-established and a cardiologist has explicitly approved PDE5 inhibitor use.
• Unstable angina or angina during sexual activity: Sexual activity itself is a cardiovascular stressor. Men whose angina is not stably controlled, or who experience angina during sexual activity, should not use Carevitra without cardiological assessment.
• Severe hypotension (below 90/50 mmHg): Carevitra's blood-pressure-lowering effect is contraindicated in already hypotensive patients.
• Retinitis pigmentosa: This hereditary progressive retinal dystrophy involves compromised retinal vasculature and abnormal PDE6 expression. The small ocular risk associated with PDE5 inhibitors is disproportionately elevated in this population.
• Under 18 years of age: Carevitra is not indicated for or approved in pediatric patients and should never be used by anyone under 18.
• Women: Carevitra is not intended for use by women and has not been studied for efficacy or safety in women.

Drug Interactions: Critical Information for Safe Use

Nitrates — Absolute Contraindication (See Above)

The nitrate interaction is the most clinically critical issue with Carevitra. It is comprehensively covered in the contraindications section. The key additional nuance: men who have taken vardenafil must avoid all nitrates for at least 24 hours after the last dose, as vardenafil remains pharmacologically active in the body throughout this period.

Alpha-Adrenergic Receptor Blockers

Alpha-blockers (doxazosin, tamsulosin, terazosin, alfuzosin, silodosin) are prescribed for BPH and sometimes for hypertension. They lower blood pressure independently. When combined with vardenafil, the additive hypotensive effect can produce symptomatic hypotension — dizziness and fainting — particularly with the first combined dose.

Specific FDA-issued guidance for vardenafil and alpha-blockers: Start with the lowest vardenafil dose (5 to 10 mg) when already on stable alpha-blocker therapy. Allow at least 6 hours between taking an alpha-blocker and taking vardenafil, particularly with doxazosin. Tamsulosin at 0.4 mg has demonstrated a more favorable hemodynamic interaction profile with vardenafil and is generally considered the safest alpha-blocker to combine.

CYP3A4 Inhibitors — Significant Interactions

Vardenafil is metabolized primarily by hepatic CYP3A4 (and to a lesser extent by CYP2C9). Drugs that inhibit CYP3A4 raise vardenafil plasma concentrations, amplifying both efficacy and side-effect risk:

• Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, clarithromycin, nelfinavir): Dramatically increase vardenafil exposure. Ritonavir at 600 mg twice daily increases vardenafil AUC by approximately 49-fold. Vardenafil must not be used with ritonavir. With ketoconazole 200 mg, maximum vardenafil dose is 5 mg per 24 hours. With ketoconazole 400 mg or other strong inhibitors, maximum dose is 2.5 mg per 24 hours.
• Moderate inhibitors (erythromycin, fluconazole, diltiazem, verapamil, amprenavir, fosamprenavir): Produce moderate increases in vardenafil levels. Physician dose adjustment guidance should be followed.
• Grapefruit juice: Inhibits intestinal CYP3A4 and CYP2C9, unpredictably raising vardenafil bioavailability. Avoid entirely throughout treatment.

QT-Prolonging Drugs

Because vardenafil has mild QT-prolonging effects at supratherapeutic doses, it should be used cautiously alongside other QT-prolonging drugs: class IA antiarrhythmics (quinidine, procainamide, disopyramide), class III antiarrhythmics (amiodarone, sotalol), and certain antibiotics (moxifloxacin). In men already on these medications, an ECG evaluation before initiating vardenafil is prudent.

Antihypertensive Medications

Men on stable, well-controlled antihypertensive drug regimens can generally use Carevitra safely, as the additional blood pressure reduction from vardenafil alone is typically modest and clinically manageable in controlled hypertension. Starting at the lower 10 mg dose rather than 20 mg is a sensible precaution for the first dose, allowing individual blood pressure response to be assessed.

Carevitra in Special Patient Populations

Diabetic Men

As discussed in the clinical evidence section, vardenafil has the strongest and most consistently demonstrated efficacy data in diabetic men of any PDE5 inhibitor in comparative analyses. This positions Carevitra as a particularly well-supported choice for the large and growing population of American men with Type 1 or Type 2 diabetes who experience ED — without any requirement for dose adjustment specifically for diabetes.

Men With Hypertension

High blood pressure is among the most common causes of vasculogenic ED, damaging endothelial cells and reducing nitric oxide bioavailability throughout the vascular tree. Vardenafil has been extensively studied in hypertensive men on stable pharmacological management and shown to be effective and well-tolerated. Starting at 10 mg for the first dose, with appropriate monitoring for blood pressure response, is the recommended approach.

Men Over 65

Pharmacokinetic studies show that Cmax (peak plasma concentration) and AUC (total exposure) are approximately 34 to 52% higher in men over 65 than in younger adults, reflecting reduced hepatic metabolism with age. FDA labeling therefore recommends a starting dose of 5 mg for men aged 65 and older, with subsequent titration to 10 mg or 20 mg based on efficacy and tolerability. The full clinical benefit of vardenafil remains available to older men — careful dose titration simply ensures the best benefit-risk balance.

Men With Mild to Moderate Hepatic Impairment

Men with mild hepatic impairment (Child-Pugh A) can typically use standard Carevitra dosing. Men with moderate hepatic impairment (Child-Pugh B) should start at 5 mg and not exceed 10 mg per dose. Severe hepatic impairment (Child-Pugh C) is a contraindication, as discussed above.

Men With Renal Impairment

Because vardenafil is primarily hepatically metabolized rather than renally cleared, dose adjustment is generally not required for mild to moderate chronic kidney disease. For men with end-stage renal disease not on dialysis, standard dosing is typically used. Dialysis patients require individual physician assessment.

Getting the Most from Carevitra: Lifestyle Factors That Amplify Results

The Vascular Foundation of Erectile Health

Erectile dysfunction, in the majority of cases, is a vascular disease — a manifestation of the same endothelial dysfunction, arterial stiffening, and reduced nitric oxide bioavailability that underpins hypertension, coronary artery disease, and peripheral vascular disease. ED frequently presents 3 to 5 years before the first cardiac event, making it a critical early warning sign that physicians are increasingly recognizing. The lifestyle interventions that improve cardiovascular health directly improve the physiological substrate that Carevitra depends on to work optimally.

Aerobic Exercise

Regular aerobic exercise is the most evidence-supported non-pharmacological intervention for erectile function. A 2018 meta-analysis of 10 randomized controlled trials concluded that aerobic exercise — specifically, moderate-intensity aerobic activity for 40 minutes, 4 days per week — produced statistically significant and clinically meaningful improvements in erectile function independent of medication. The mechanisms are multiple: improved endothelial function, increased nitric oxide production, enhanced arterial elasticity, reduced inflammation, improved testosterone levels, and reduced anxiety.

Diet

The Mediterranean dietary pattern — characterized by high consumption of vegetables, fruits, whole grains, legumes, olive oil, fish, and moderate wine — has been associated in multiple large epidemiological studies with significantly lower ED prevalence. A prospective study involving over 25,000 men found that adherence to a Mediterranean or MIND diet was associated with a 10 to 19% lower risk of ED. Abdominal obesity specifically — a hallmark of Western dietary excess — drives the metabolic syndrome that is one of the strongest modifiable risk factors for ED.

Smoking Cessation

Tobacco smoking is one of the most powerful modifiable risk factors for erectile dysfunction. Nicotine and tobacco combustion byproducts directly damage vascular endothelium, reduce arterial elasticity, decrease nitric oxide bioavailability, and accelerate systemic atherosclerosis — all of which directly impair the vascular mechanism underlying erection. Clinical studies show that men who quit smoking experience measurable improvements in erectile function within 2 to 6 months of cessation, with further gains as vascular health progressively recovers.

Managing Psychological Contributors

Performance anxiety is one of the most common drivers of erectile dysfunction in men under 45 — and one of the most responsive to treatment. Carevitra can powerfully break the anxiety cycle by restoring reliable erections and rebuilding sexual confidence. However, for men in whom psychological factors dominate, combining medication with cognitive behavioral therapy (CBT), mindfulness-based sex therapy, or couples counseling consistently produces better long-term outcomes than medication alone. A sex therapist experienced with ED can help address the psychological component that pharmacology alone cannot resolve.

Carevitra and Sexual Performance: Common Questions Answered

Does Carevitra Help With Premature Ejaculation?

Carevitra treats erectile dysfunction — the inability to achieve or maintain an adequate erection. It does not directly target premature ejaculation (PE), which is regulated by different serotonergic and adrenergic neurophysiological pathways. However, an important indirect pathway exists: the performance anxiety and loss of sexual confidence that accompany ED frequently trigger or worsen PE. By restoring reliable erections and reducing performance anxiety, Carevitra often produces secondary improvements in ejaculatory control in men where anxiety was the primary driver.

For men dealing with both conditions, we recommend reading our comprehensive blog guide How Do People Last in Bed for So Long? — which covers behavioral techniques, pharmacological options, and combined approaches for improving sexual endurance.

Combining Carevitra With a Delay Spray

For men who experience both ED and PE simultaneously, combining Carevitra with a topical delay formulation can address both issues in the same session. Our Climax Delay Spray applies a mild lidocaine-based local anesthetic that reduces penile hypersensitivity and extends intravaginal ejaculation latency, complementing Carevitra's erectile support for a comprehensive performance enhancement approach. The two formulations address entirely different physiological targets and can be safely combined.

Carevitra and ED Oral Jelly

Some men prefer to vary their ED medication format depending on circumstances. For occasions when a faster-dissolving, water-free format is preferred, our ED Oral Jelly collection includes sildenafil-based jelly sachets that absorb rapidly through the oral mucosa for quick onset. Many men who primarily use Carevitra tablets keep oral jelly sachets as an alternative for specific situations — travel, spontaneity, or when swallowing a tablet is inconvenient.

Generic Carevitra vs. Brand-Name Levitra: Is There Really a Difference?

The question that every first-time buyer of generic ED medication reasonably asks: is Carevitra actually equivalent to brand-name Levitra? The scientific and regulatory answer is clear and unambiguous: yes, generics and brand-name drugs containing the same active ingredient in the same dose and dosage form are required by law to be bioequivalent.

Bioequivalence — as defined by the FDA — requires that the generic product deliver the active ingredient to the bloodstream at the same rate and to the same total extent as the reference listed drug, within a statistically accepted confidence interval. For oral tablet formulations of well-characterized small-molecule drugs like vardenafil, this standard reliably translates to equivalent clinical efficacy and safety in real-world use.

The vardenafil molecule in a Carevitra 20 mg tablet is chemically and pharmacologically identical to the vardenafil in a brand-name Levitra 20 mg tablet. The differences between the two products are confined entirely to the inactive ingredients — the binders, fillers, disintegrants, and tablet coatings. These affect appearance and potentially subtle dissolution kinetics but have no bearing on the pharmacological action of vardenafil in the body.

Brand-name Levitra is largely discontinued in the U.S. market (as of around 2020, Bayer's brand-name Levitra is not actively marketed). FDA-approved generic vardenafil, however, remains fully available through licensed pharmacies. The practical benefit of Carevitra is twofold: the same active ingredient at a dramatically more accessible price, and the availability of multiple dose strengths (including 40 mg and 60 mg) that were not commercially offered under the original brand.

Why Buy Carevitra From ED Care Store?

We built ED Care Store with one central conviction: every American man deserves affordable, discreet, and reliable access to the ED medication that works best for him — without insurance barriers, without judgment, and without paying brand-name prices for a generic molecule. Here is what makes us the right choice:

• All three Carevitra strengths stocked: Carevitra 20 mg, 40 mg, and 60 mg are all available in our catalog — giving you and your physician genuine flexibility in dose selection without hunting across multiple pharmacies.
• Competitive, transparent pricing: Our prices are clearly displayed with no hidden fees, no surprise charges at checkout, and no subscription required.
• Discreet packaging on every order: Every order ships in plain, unmarked exterior packaging. The contents are never identified on the box, the packaging tape, or the return address. Your privacy is our unconditional commitment.
• Trackable, reliable delivery: We ship with proven logistics partners to ensure your order arrives as expected with full tracking visibility.
• Expert-researched product information: Every guide, comparison, and product description we publish is grounded in clinical evidence and written to serve your genuine informational needs.
• Responsive customer support: Real support available to assist with order questions, shipping concerns, product guidance, and anything else you need.

Browse our complete Men's Health collection to explore our full range of ED treatments. Review our shipping policy for full information on delivery timelines and packaging. And if you have questions about any product, our contact page connects you directly with our team.

Not sure whether Carevitra, a sildenafil generic, or a tadalafil option is the right choice for you? Read our comprehensive comparison blog post: What Is the Best Pill for ED? — a straightforward guide to all major ED medications designed to help American men make confident, informed treatment decisions.

Frequently Asked Questions About Carevitra

Q: How fast does Carevitra start working?

Most men experience the onset of Carevitra's effects within 25 to 60 minutes of taking the tablet. On an empty or light-food stomach, effects can begin in as little as 25 to 30 minutes. With a moderate meal, 45 to 60 minutes is a more reliable expectation. A high-fat meal can push onset to 90 minutes or more — avoid heavy meals if you want consistent, predictable timing.

Q: How long does Carevitra stay effective?

The therapeutic window — the period during which enhanced erectile responsiveness is reliably expected — is approximately 4 to 6 hours for most men. This is broadly similar to sildenafil (Viagra) and shorter than tadalafil (Cialis/Vidalista), which lasts up to 36 hours. For men who prefer a finite, well-defined active window, vardenafil's 4 to 6 hour duration is often a practical preference.

Q: What makes Carevitra different from Viagra?

Both are PDE5 inhibitors that work through the same fundamental mechanism, but vardenafil (Carevitra) has meaningfully different pharmacological characteristics: significantly lower PDE6 inhibition (meaning far fewer visual side effects), higher PDE5 binding affinity (meaning stronger PDE5 inhibition per milligram), and superior efficacy data in diabetic populations. For men who have experienced blue-tinge vision or light sensitivity with sildenafil, or who have diabetes, Carevitra is frequently the better-tolerated and more effective choice.

Q: Can I take Carevitra with blood pressure medication?

For most men on stable, well-managed antihypertensive therapy who are NOT taking nitrate-based medications, Carevitra can be used safely with appropriate starting-dose caution (10 mg for the first dose rather than 20 mg). Men taking alpha-blockers for BPH require specific timing and dose precautions. The absolute exception is nitrate medications — this combination is unconditionally contraindicated regardless of dose or timing.

Q: Will Carevitra work the first time I take it?

Most men experience a meaningful improvement in erectile function on the first dose. However, a significant proportion of men see their best results on the second or third use — once the performance anxiety that commonly accompanies the first use of a new ED medication has diminished and sexual confidence has been restored. If the first dose doesn't produce the result you hoped for, evaluate timing, stimulation, food and alcohol consumption before concluding the medication isn't effective for you.

Q: Is Carevitra safe for long-term use?

Long-term extension data from clinical trials spanning two to four years of continuous use show that vardenafil's safety and efficacy profiles are stable over time. No tolerance to the therapeutic effect develops with long-term use. The adverse event pattern does not worsen with continued exposure. As with all prescription medications, periodic reassessment with your prescribing physician is appropriate for long-term users.

Q: What should I do if I experience side effects?

Common, mild side effects (headache, flushing, nasal congestion, mild dizziness) typically resolve within 2 to 4 hours without intervention. Standard analgesics can help with headache. If side effects are persistent, distressing, or severe, contact your physician. For priapism (erection lasting more than 4 hours), sudden vision loss, or sudden hearing loss, seek emergency care immediately without delay.

Q: Is Carevitra the same as Levitra?

The active ingredient — vardenafil — is chemically identical. Bioequivalence standards ensure the same pharmacological exposure. The practical differences are price (Carevitra is significantly more affordable) and the availability of higher strengths (40 mg and 60 mg) that were not routinely available under the original Levitra branding. For clinical purposes, they are equivalent.

Conclusion: Is Carevitra the Right ED Treatment for You?

Carevitra represents one of the most precisely engineered and clinically validated treatments for erectile dysfunction available to American men. Its active ingredient vardenafil's superior PDE5 selectivity, significantly lower visual side-effect profile, robust diabetic ED efficacy, and fast onset make it a genuinely differentiated option — not simply a Viagra equivalent with a different name.

The three-strength lineup (20 mg, 40 mg, 60 mg) accommodates a wide range of clinical presentations, from straightforward mild-to-moderate ED responding well to the standard 20 mg dose to more challenging cases requiring physician-supervised higher-dose therapy. And with generic pricing making vardenafil accessible at a fraction of the original brand cost, the financial barrier that has historically kept too many American men from effective treatment is substantially reduced.

Always work with a licensed healthcare provider to confirm vardenafil is appropriate for your health profile, to select the correct starting dose, and to review potential drug interactions — especially if you are taking nitrate medications, alpha-blockers, or CYP3A4 inhibitors. Then, when you are ready, trust ED Care Store to deliver exactly what you ordered, packaged discreetly, at a price that respects your budget.

Medical Disclaimer: The content in this article is provided by ED Care Store for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Carevitra (vardenafil) is a prescription medication in the United States. Always consult a licensed physician before starting, stopping, or adjusting any medication. Never combine Carevitra with nitrate medications or riociguat — these combinations can be life-threatening. Never use Carevitra if you have congenital QT prolongation or are taking QT-prolonging antiarrhythmics. Individual results vary. All products are subject to applicable laws, valid prescription requirements, and our platform's terms and conditions.